Jeffrey M. Crane

474 total citations
10 papers, 357 citations indexed

About

Jeffrey M. Crane is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Jeffrey M. Crane has authored 10 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Jeffrey M. Crane's work include Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer survivorship and care (2 papers). Jeffrey M. Crane is often cited by papers focused on Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer survivorship and care (2 papers). Jeffrey M. Crane collaborates with scholars based in United States and Canada. Jeffrey M. Crane's co-authors include Paul A. Godley, W. Kimryn Rathmell, Raj S. Pruthi, Young E. Whang, Dominic T. Moore, Eric Wallen, William Y. Kim, Gayle Grigson, Daniel C. Ihde and Eli Glatstein and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jeffrey M. Crane

9 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey M. Crane United States 7 280 153 146 91 41 10 357
Shiven B. Patel United States 12 168 0.6× 276 1.8× 106 0.7× 41 0.5× 36 0.9× 47 420
Won Jin Chang South Korea 12 110 0.4× 177 1.2× 79 0.5× 91 1.0× 39 1.0× 27 353
Malinda Itchins Australia 12 202 0.7× 285 1.9× 67 0.5× 88 1.0× 73 1.8× 45 411
Vincent Verschaeve Belgium 9 147 0.5× 112 0.7× 157 1.1× 59 0.6× 21 0.5× 21 389
Asif Talukder United States 11 126 0.5× 222 1.5× 126 0.9× 68 0.7× 21 0.5× 19 443
Tristan Maurina France 10 154 0.6× 108 0.7× 118 0.8× 73 0.8× 24 0.6× 30 293
JN Atkins United States 11 200 0.7× 303 2.0× 117 0.8× 143 1.6× 20 0.5× 22 500
Humera Khurshid United States 11 137 0.5× 190 1.2× 70 0.5× 41 0.5× 22 0.5× 24 342
L Portalone Italy 11 427 1.5× 418 2.7× 156 1.1× 84 0.9× 60 1.5× 26 668
M. Lomas Spain 7 364 1.3× 419 2.7× 94 0.6× 52 0.6× 39 1.0× 23 518

Countries citing papers authored by Jeffrey M. Crane

Since Specialization
Citations

This map shows the geographic impact of Jeffrey M. Crane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Crane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Crane more than expected).

Fields of papers citing papers by Jeffrey M. Crane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey M. Crane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Crane. The network helps show where Jeffrey M. Crane may publish in the future.

Co-authorship network of co-authors of Jeffrey M. Crane

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Crane. A scholar is included among the top collaborators of Jeffrey M. Crane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Crane. Jeffrey M. Crane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Crane, Jeffrey M., et al.. (2024). 228 Physical literacy and inclusion within the context of disability and impairment: A multiple case study approach. European Journal of Public Health. 34(Supplement_2).
2.
Weiss, Jared, Nathan A. Pennell, Allison M. Deal, et al.. (2020). Nab‐paclitaxel in older patients with non–small cell lung cancer who have developed disease progression after platinum‐based doublet chemotherapy. Cancer. 126(5). 1060–1067. 12 indexed citations
3.
Mayer, Deborah K., Allison M. Deal, Jeffrey M. Crane, et al.. (2016). Using Survivorship Care Plans to Enhance Communication and Cancer Care Coordination: Results of a Pilot Study. Oncology nursing forum. 43(5). 636–645. 27 indexed citations
4.
Mayer, Deborah K., Allison M. Deal, Jeffrey M. Crane, et al.. (2015). Using survivorship care plans (SCP) to improve cancer communication and care coordination.. Journal of Clinical Oncology. 33(15_suppl). 9580–9580. 3 indexed citations
5.
Chen, Ronald C., Julian Rosenman, Andrew Z. Wang, et al.. (2012). Phase I study of concurrent weekly docetaxel, high‐dose intensity‐modulated radiation therapy (IMRT) and androgen‐deprivation therapy (ADT) for high‐risk prostate cancer. British Journal of Urology. 110(11b). E721–6. 17 indexed citations
6.
Whang, Young E., Andrew J. Armstrong, W. Kimryn Rathmell, et al.. (2011). A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer. Urologic Oncology Seminars and Original Investigations. 31(1). 82–86. 69 indexed citations
7.
Stinchcombe, Thomas E., Amy H. Peterman, Carrie B. Lee, et al.. (2011). A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(9). 1569–1577. 30 indexed citations
8.
Cowey, C. Lance, Chirag Amin, Raj S. Pruthi, et al.. (2010). Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma. Journal of Clinical Oncology. 28(9). 1502–1507. 143 indexed citations
9.
Crane, Jeffrey M., et al.. (2001). Quality Improvement Efforts in Oncology: Are We Ready to Begin?. Cancer Investigation. 19(1). 86–95. 4 indexed citations
10.
Carmichael, James, Jeffrey M. Crane, Paul A. Bunn, Eli Glatstein, & Daniel C. Ihde. (1988). Results of therapeutic cranial irradiation in small cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 14(3). 455–459. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026